Bills represent a bipartisan commitment to end a public health crisis that affects tens of millions of Americans

Washington, DC (July 30, 2024) — The United States Senate passed two key bills aimed at reinforcing Alzheimer’s as a national priority and increasing accountability in federal funding.

Reauthorization of the National Alzheimer’s Project Act (NAPA), a major priority of UsAgainstAlzheimer’s, approaches Alzheimer’s as the public health crisis it is. Specifically, NAPA aims to prevent and effectively treat Alzheimer’s and related dementias by 2035 while expanding support for people living with the disease and their families, and increasing public awareness.

The Alzheimer’s Accountability and Investment Act would enhance accountability and transparency in federal funding for Alzheimer’s by requiring the National Institutes of Health (NIH) to submit an annual budget and estimated personnel needed to do the work associated with NAPA.

“These two bills are incredibly important to the work we are doing to end the scourge of Alzheimer’s,” said George Vradenburg, chair and co-founder of UsAgainstAlzheimer’s. “By reinforcing our national commitment to fighting this crisis and requiring accountability for every federal dollar spent, these bills help ensure that our country will keep its foot on the gas to stop this disease. We look forward to working with Health and Human Services on establishing new national goals for 2035 and engaging the business community in those conversations so we can address the enormous economic impact of Alzheimer’s. We’re also grateful for the leadership of Senators Collins, Markey, Warner, and Capito and for every member of the Senate who joined them in getting these bills across the finish line.”

# # #

About UsAgainstAlzheimer’s
UsAgainstAlzheimer’s is engaged in a relentless pursuit to end Alzheimer’s, the sixth leading killer in America. Our work centers on prevention, early detection and diagnosis, and equal access to treatments regardless of gender, race, or ethnicity. To achieve our mission, we give voice to patients and caregivers while partnering with government, scientists, the private sector, and allied organizations -- the people who put the “Us” in UsAgainstAlzheimer’s.